Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Inn Med (Heidelb) ; 65(8): 843-849, 2024 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-38459200

RESUMO

A 42-year-old female patient was admitted to hospital due to acute neurological symptoms (dysarthria, disorientation). After exclusion of cerebral ischemia and hemorrhage an autoimmune encephalitis was diagnosed. Shortly before as an outpatient the suspicion of the presence of systemic lupus erythematosus (SLE) was voiced. The patient showed a constellation of high levels of inflammatory laboratory parameters and within a few days developed a severe pancytopenia. In the presence of all diagnostic criteria a secondary hemophagocytic lymphohistiocytosis (sHLH) was diagnosed and confirmed by a kidney biopsy during the course of the underlying SLE. The immunosuppressive treatment with etoposide and high-dose dexamethasone according to the HLH-94 protocol only showed temporary success. After 3 weeks of treatment with a protocol-conform dose reduction, under running treatment a new exacerbation of symptoms was confirmed. A renewed dose escalation of the drugs used did not lead to control of the symptoms. The inflammatory activity could only be sustainably controlled by the use of cyclosporin A in combination with mycophenolate mofetil (MMF) and dexamethasone. After stabilization of the condition of the patient, an outpatient follow-up care was possible.


Assuntos
Ciclosporina , Dexametasona , Quimioterapia Combinada , Imunossupressores , Lúpus Eritematoso Sistêmico , Linfo-Histiocitose Hemofagocítica , Ácido Micofenólico , Humanos , Feminino , Linfo-Histiocitose Hemofagocítica/tratamento farmacológico , Linfo-Histiocitose Hemofagocítica/patologia , Dexametasona/uso terapêutico , Dexametasona/administração & dosagem , Adulto , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Ácido Micofenólico/uso terapêutico , Ciclosporina/uso terapêutico , Ciclosporina/administração & dosagem , Imunossupressores/uso terapêutico , Imunossupressores/administração & dosagem , Recidiva
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...